Snezana Neff

Title: Snezana Neff: Innovator in Polyketide Antibiotic Production

Introduction

Snezana Neff is a prominent inventor based in Bubendorf, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the production of polyketide antibiotics. With a total of 3 patents, her work has the potential to impact various applications in medicine and agriculture.

Latest Patents

One of her latest patents focuses on the genes for the biosynthesis of soraphen. This invention is directed towards the production of a polyketide antibiotic, such as soraphen, through recombinant expression of the necessary polypeptides. The patent provides polyketide synthase (PKS) genes that encode the polypeptides essential for synthesizing soraphen. Additionally, it includes methods for identifying and isolating the PKS genes required for the recombinant biosynthesis of any desired polyketide antibiotic. The cloned PKS genes can be transformed and expressed in host organisms to produce soraphen, which can serve various purposes, including protecting the host from pathogens and developing the host as a biocontrol agent.

Career Highlights

Snezana Neff is currently employed at Novartis Finance Corporation, where she continues to advance her research in biotechnology. Her innovative work has garnered attention in the scientific community, and she is recognized for her contributions to antibiotic production.

Collaborations

Throughout her career, Snezana has collaborated with notable colleagues, including Thomas Schupp and James Madison Ligon. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Snezana Neff is a trailblazer in the field of biotechnology, with her inventions paving the way for advancements in antibiotic production. Her work exemplifies the importance of innovation in addressing challenges in health and agriculture.